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Abstract: Acid-sensing ion channels (ASICs) are H+-gated Na+ channels, which are present in most, if not all, neurons.
The typical ASIC current is transient and is elicited by a rapid drop in the extracellular pH. In the human genome, four
genes for ASICs are present: asic1 – 4. In this review, we will focus on ASIC1a, one of the key subunits in the central
nervous system. We will describe the structure of this channel, a topic that has enormously profited from the recent
elucidation of the first crystal structure of an ASIC. We will then relate the ASIC1 structure to current models of the
gating mechanism of ASICs. Finally, we will review the pharmacology of ASIC1a. Advances in the pharmacological
inhibition of individual ASIC currents have greatly contributed to our current knowledge of the functional roles of this
channel in physiology, including learning, memory, and fear conditioning, and in pathophysiological states, including
the neurodegeneration accompanying stroke, and axonal degeneration in autoimmune inflammation.
Keywords: Acidosis , desensitization, excitatory postsynaptic current, fear conditioning, ischemia, psalmotoxin

Introduction
In 1981, Krishtal and Pidoplichko described for
the first time a receptor for H+ that carried inward Na+ currents in mammalian sensory neurons [1, 2]. It was not until 1997 that the group
of Lazdunski cloned a channel from rat brain
that was directly activated by H+ and carried an
excitatory Na+ current [3]. This channel, ASIC1a,
was just the first member of a small family of H+
-gated channels. Thanks to recent work in many
laboratories, we now have a clearer picture of
the physiological function of these H+-gated
channels and there are clear indications that
ASICs contribute to the outcome of several
pathophysiological states.
ASIC1a had been cloned by its homology to the
amiloride-sensitive epithelial Na+ channel
(ENaC), with which it shares approximately 25%
amino acid sequence identity [3]. Other homologues of ASICs include peptide-gated channels
from polyps [4] and mollusks [5] and mechanosensitive channels (the degenerins or “DEG”
channels) from C. elegans [6]. Thus, ASICs de-

fine a branch of the DEG/ENaC family of ion
channels. Since the most ancient DEG/ENaC
channels that have been characterized so far
are peptide-gated channels from the cnidarian
Hydra, the HyNaCs [4], and since HyNaCs are
close relatives of ASICs within the DEG/ENaC
gene family [4], it is conceivable that H+-gated
ASICs evolved from peptide-gated channels.
So far, ASICs have been identified exclusively in
chordates (Figure 1). A single ASIC gene is already found in the genome of Ciona intestinalis
[7], an urochordate that belongs to the earliest
branch in the chordate phylum. Moreover, ASICs
have been cloned from a jawless vertebrate
(lamprey) [8], from cartilaginous fish (shark) [8],
from bony fish (toadfish and zebrafish) [9, 10],
from chicken [8] and different mammals
(mouse, rat, human) (Figure 1).
ASICs are defined by their sequence homology;
functionally, some ASICs, like ASIC2b and
ASIC4, are not sensitive to acid [11-13] and the
function of those subunits is not always known.
ASIC2b contributes to proton-sensing by forming
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Figure 1: A) Phylogenetic tree illustrating the relationship of selected ASICs. Note that a clear ASIC1 ortholog is present in all vertebrate lineages, whereas ASIC3 has so far only been identified in mammalian species. The urochordate
Ciona contains a single asic gene [7], whereas in mammals the number of asic genes has increased to four. Amino
acid sequences of selected ASICs were aligned and the tree for the cladogram established by neighbor joining using
ClustalX (DNAstar software); sequences at the N- and C-termini had been deleted. The related brain-liver-intestine
Na+ channel (BLINaC) form rat [156] was included for comparison. B) Phylogenetic tree of the chordate phylum. Main
chordate clades are shown. The color corresponds to the color of ASICs from organisms of these clades in (A). So far,
no ASICs have been reported from cephalochordates and amphibians; their existence in these clades is, however,
likely.

heteromeric channels with other ASICs [11]; the
function of ASIC4, however, is unknown and
current evidence suggests it is not involved in
H+-sensing [12]. On the other hand, some DEG/
ENaC members, which do not belong to the
ASIC branch, are sensitive to H+. For example,
acid-sensitive channel, degenerin-like (ACD-1)
from C. elegans, which is most closely related to
degenerins, is inhibited by intra- and extracellular acidification [14]. Another protein from C.
elegans with sequence homology to DEG/ENaC
channels has been dubbed ASIC-1 [15]. Since
this channel does not belong to the ASIC branch
of the DEG/ENaC family and functional expression, let alone H+-sensitivity, has not been described, this name is misleading and the protein
should be renamed.
In the present review we will focus on ASIC1.
ASIC1 is the most abundant ASIC subunit in the
mammalian central nervous system (CNS). In
addition, in the CNS it is the ASIC with the high-
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est H+-affinity; ASIC3 is equally sensitive to H+
but restricted to the peripheral nervous system
(PNS) [16]. However, one recent study has reported expression of ASIC3 in rat hypothalamus
[17]. Moreover, homomeric ASIC1a is the only
ASIC that is slightly permeable to Ca2+ [3, 18,
19]. The importance of ASIC1a in the CNS is
underlined by the fact that it is apparently involved in a number of neurodegenerative diseases (see below). Finally, chicken ASIC1 is the
only ASIC that has been crystallized [20] and
the gating mechanism of ASIC1 has been elucidated in some detail. The ASIC1 gene gives rise
to two variants – ASIC1a and ASIC1b [19, 21].
The splice variant ASIC1b is restricted to the
PNS [21], like ASIC3, and its physiological functions are largely unknown. Moreover, although
an ASIC1b gene is present in the human genome, clear evidence for an ASIC1b cDNA in
humans is lacking. Therefore, we will discuss
ASIC1b only where it sheds further light on the
properties of ASIC1a.
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We will start with a short description of the biophysical properties of ASIC1a. We will then discuss current models of the gating mechanism of
ASIC1a, review its pharmacology and will then
briefly introduce what we know about the
physiological functions of ASIC1a and its implications in the pathogenesis of neurodegenerative diseases. Most of the discussion will be on
homomeric ASIC1a; it is known, however, that
heteromers containing ASIC1a also mediate H+gated currents in many neurons. In the CNS,
homomeric ASIC1a and heteromeric ASIC1a/2a
are the major ASICs [22-24].
Biophysical properties of ASIC1a
In most studies, ASIC1a starts to open at pH 6.9
[3, 25]; current amplitude then increases with
increasing H+ concentrations down to pH 6.0,
where ASIC current amplitude starts to saturate.
The H+-concentration response curve can be fit
by a Hill function and yields half-maximal activation at pH 6.5 with a Hill-coefficient of approximately 3 [3, 25]. Very recently, it has been
shown that in neurons acutely dissociated from
the amygdala, ASICs containing the ASIC1a subunit are even more sensitive to H+: channels
opened at pH 7.2 [26]. Whether this extreme
sensitivity to tiny variations in the H+ concentrations is due to formation of heteromeric channels, or, more likely, to some modulation by accessory proteins or other unknown factors,
awaits further studies.
ASIC1a desensitizes completely with a time constant of 1 - 2 sec [3, 19]. Complete desensitization means that ASIC1a cannot encode sustained acidification. It recovers from desensitization within a few seconds [25]. Desensitization of ASIC1a starts at pH values slightly below
pH 7.4 and during prolonged acidification to pH
values below 7.1 all ASIC channels are in the
desensitized state [25]. Thus, ASIC1a can enter
the desensitized state without apparent opening. This steady-state desensitization (SSD) can
also be fit by a Hill function: for rat ASIC1a it is
half-maximal at pH 7.25 and has a Hill coefficient of approximately 10 [25]; for mouse and
human ASIC1a, it is half-maximal at pH 7.15
and 6.90, respectively [27]. Thus, SSD seems to
be a process completely separate from activation, with a higher H+ affinity.
This conclusion is not necessarily true, however.

75

At low H+ concentrations (for rat, between pH
7.4 and 6.9) channels may open with a low
probability. The unconcerted opening (and subsequent desensitization) of individual channels
would not lead to visible currents in whole cell
measurements and pass unnoticed. In agreement with such a scenario, SSD takes much
longer than open state desensitization (70 sec,
at pH 7.05, rather than 1 – 2 sec) [25]. In addition, in most mutagenesis studies where mutations changed the apparent H+ affinity of
ASIC1a, mutations also affected H+ affinity of
SSD [25], arguing that both processes are indeed intimately linked. Moreover, for the rapidly
desensitizing ATP receptor P2X1, it has been
shown that desensitization masks a higher ATP
affinity of P2X1 activation [28, 29], suggesting
that the “real” H+ affinity of ASIC1a is that of
SSD. The E79A substitution in ASIC3 is an example of a mutation that shifts the SSD curve to
10-fold lower H+ concentrations without shifting
the activation curve [30], suggesting that this
mutation uncouples SSD from activation gating.
However, since the same mutation also enhanced desensitization 4-fold [30], it is not excluded that the faster desensitization may mask
a higher H+ affinity of ASIC3 activation. In summary, whether ASIC1a channels can reach the
desensitized state directly from the closed state
and if so, to which extent this closed state desensitization contributes to SSD at slight acidification are open questions. Irrespective of this
uncertainty, all observations suggest that
ASIC1a is an exquisitely sensitive H+ receptor; if
H+ affinity were only slightly higher, the channel
would be chronically desensitized at rest.
Recently, it has been shown that the endogenous opioid peptides dynorphin A and big dynorphin shift the SSD curve of ASIC1a to lower H+
concentrations limiting the impact of SSD [31];
probably dynorphin directly binds to the extracellular loop of ASIC1a. This result suggests
that ASIC1 should be considered as a new
nonopioid target for dynorphin action in the
CNS.
For ASIC3 it has been shown that the curves of
H+ activation and SSD overlap and that in the
window of overlap ASIC3 carries sustained currents [32]. This property endows ASIC3 with the
capacity to encode also the sustained acidification in the window of overlap between pH 7.3
and 6.7. ASIC1a, however, carries no such window currents [32] and can, therefore, encode
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only the acidic transients as they may occur
during synaptic transmission.
Once gated open, the ASIC1a pore has a slight
selectivity for Na+ over K+ (PNa/PK = 10) [3, 19],
so that at a membrane potential of -70 mV,
which is much closer to the K+ than the Na+
equilibrium potential, ASIC1a mainly carries an
excitatory inward current of Na+. In addition,
homomeric ASIC1a is the only ASIC that has a
slight permeability to Ca2+ (PNa/PCa = 15) [18,
19, 33]. The fractional Ca2+ current is, however,
very small [34]. Therefore, the Ca2+ influx
through ASIC1a per se will significantly raise the
intracellular Ca2+ concentrations only in a microdomain close to the channel, if at all. Ca2+ is a
permeant blocker of ASIC1a, permeating
through the channel but also blocking it [3, 35].
Finally, ASIC1a is not only gated by H+ but also
permeable to H+ [3, 36]. Not unexpected, relative H+ permeability is higher than Na+ permeability (PNa/PH < 0.3) [36] but due to the very
small H+ concentrations (1 µM at pH 6.0) relative to the Na+ concentration (~100 mM), the
fractional H+ current will again be tiny. However,
it could lead to slight acidification in a microdomain surrounding the intracellular mouth of the
channel.
Tachyphylaxis is another peculiar feature of
homomeric ASIC1a that is specific to this subtype [36]. Tachyphylaxis means that repeated
activation of the channel leads to ever-smaller
current amplitudes even though the time interval between individual activation is sufficient for
recovery from normal desensitization. Thus,
tachyphylaxis uncovers a second long-lived desensitized state, from which the channel may
not recover [36]. Tachyphylaxis is linked to H+
influx though ASIC1a and its Ca2+ permeability
[36]. Since tachyphylaxis is especially pronounced at pH < 6 [36], it is unclear to which
extent it limits ASIC1a activity in vivo.

of the related ENaC had been established in
three independent studies [37-39] and revealed
that the two termini are located in the cytoplasm, whereas the domain between the two
hydrophobic domains, each of which spans the
membrane once, forms a large extracellular
domain (ECD). It was confirmed that ASICs have
the same transmembrane topology [40] (Figure
2B). The first exon, which is different between
ASIC1a and ASIC1b, thus comprises the intracellular N-terminus, the first transmembrane
domain (TMD) and approximately the first onethird of the ECD (Figure 2A).
A large ECD is not specific to ASICs, but shared
by all DEG/ENaC channels, although its size can
vary. Homology between different ASICs is largest in the second two-thirds of the ECD,
whereas some parts of the first one-third are
characterized by considerable sequence divergence. All ASICs have 14 conserved cysteines in
their ECD (Figure 2A), which likely stabilize the
structure of the ECD by forming disulphidebonds [41]. As almost every membrane protein,
ASICs carry at least one N-glycan in the ECD.
ASIC1a has two glycans in the distal part of the
ECD, whereas ASIC1b carries four glycans: two
in the distal part, which is identical to ASIC1a,
and two additional glycans in the proximal part
[42] (Figure 2A), which is different between
ASIC1a and ASIC1b. It has been proposed that
the two proximal glycans help in shaping the
structure of the proximal ECD of ASIC1b [42],
which may therefore be substantially different
between ASIC1a and ASIC1b.

The structure of an ASIC: pre-crystal era

The number of subunits in a functional channel
complex has been experimentally addressed in
several studies, most of the studies focusing on
ENaC and one study on FaNaC [43]. These studies came to conflicting results, most of them
proposing tetramers [43-48] and some nonamers [49, 50]; one recent study found identical
numbers of the three different ENaC subunits
(α, β, ), making a trimeric structure a minimal
subunit composition [51].

ASICs consist of 500 to 560 amino acids. The
primary structure of each ASIC subunit is characterized by two hydrophobic regions of approximately 20 amino acids, long enough to span the
lipid bilayer, rather short termini (35 – 90 amino
acids) and a large domain between the two hydrophobic domains (approximately 370 amino
acids) (Figure 2A). The transmembrane topology

Several studies, most on the ENaC [52-64] and
some on ASICs [35, 65], suggested that the
second TMD, especially the first, outer half contributes to the outer entrance and the selectivity
filter of the ion pore (Figure 2B). ENaC, which is
characterized by a high Na+ selectivity of its
pore (PNa/PK > 100), selects ions by molecular
sieving [54], largely excluding cations bigger
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Figure 2: A) Linear model of ASIC1a. The first onethird of the protein, which is different between
ASIC1a and 1b, is indicated in light grey. The two
hydrophobic domains are shown as black boxes.
The position of the two glycosylation sites of
ASIC1a are indicated by a branched symbol and
the two additional glycosylation sites, which are
specific for ASIC1b, are shown in grey. The 14
cysteines that are conserved in ASICs are shown
as black dots; 10 of them cluster in one region. B)
Model of the transmembrane topology of ASIC1a
from the pre-crystal era. TMD2 faces the ion pore,
the three residues (G-A-S) that probably form the
ion-selective part of the molecular sieve [53, 55,
59] are magnified in the inset. Residues within the
intracellular N-terminus that have been implicated
in contributing to the internal pore of ASIC1a [65]
or ASIC2 [66] are marked in the inset in dark and
light blue, respectively. Amino acids in this region
also determine Ca2+-permeability of ASIC1a [18].
The amino acid sequence from rat ASIC1a is
shown. The two invariably conserved amino acids
(H-G) in the cytoplasmic N-terminus that are involved in gating of ENaC [67, 68] are marked in
orange. The four amino acids (D-F-T-C) at the cytoplasmic C-terminus that bind to the PDZ domain of
PICK1 [69, 70] are also magnified in an inset.

than Na+. The narrowest part of the pore, representing the ion-selective part of this molecular
sieve, is formed by three amino acids, which are
in the middle of the second TMD [54, 56, 60]. In
all ASICs, these three amino acids are (from Nto C-terminus or outside to inside) Gly-Ala-Ser
(Gly442–Ser444 in rat ASIC1a; Figure 2B), amino
acids with small side chains. For ENaC, it was
proposed that the side chains of these three
amino acids do not point toward the lumen of
the pore but rather towards subunit-subunit
interfaces [61]. Thus, the backbone of the peptide would face the lumen of the selectivity filter
and help to coordinate permeating ions; a similar situation is found in the P-loop of Kchannels. The inner entrance to the ASIC pore is
much less characterized [66].
Surprisingly, the second TMD is identical between ASIC1a and ASIC1b, yet ASIC1a is permeable to Ca2+ whereas ASIC1b is not [19]. The
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difference in Ca2+-selectivity has been attributed
to the different intracellular N-terminus [19],
suggesting that this part of the protein helps to
shape the structure of the ion pore, perhaps by
long-range allosteric effects. Other studies also
demonstrate a role for the amino terminus in
ion selectivity [67] and participation in the internal pore [66] of ASICs (Figure 2B).
Two amino acids (His-Gly) at the intracellular Nterminus (Figure 2B) are invariably conserved in
all DEG/ENaC channels. Also their distance to
the beginning of the first TMD (approximately
15 amino acids) is within one or two amino acids invariable, suggesting that these two amino
acids have some crucial function for all DEG/
ENaC channels. In ENaC, these two amino acids
plus a few surrounding amino acids, which are
also similar across the whole gene family, are
crucial for the gating of this channel [68, 69],
defining a ”gating domain“. It is likely that they
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have a similar function in ASICs.
The function of the cytoplasmic C-terminus for
ASICs is less well established. Actually the Cterminus can be quite short (≥40 amino acids)
in some ASICs. Although the ASIC C-terminus is
not indispensable for channel activity (see below), it may be quite important for the physiological regulation of ASIC function. For example,
ASIC1a interacts with its extreme C-terminus
(Figure 2B) with the PDZ domain of the protein
interacting with C kinase (PICK1) [70, 71]. No
interactions have been directly demonstrated
for ASIC1b, but since the C-terminus of ASIC1b
is identical to that of ASIC1a, in principle at
least, this subtype can also interact with PICK1.
In addition to protein-protein interactions mediated by the C-terminus of ASIC1a, in dorsal root
ganglion neurons ASIC1a physically interacts
with its N-terminus with annexin light chain p11,
increasing surface-expression of ASIC1a [72].
In summary, in the pre-crystal era we had a picture of ASICs being made of probably four subunits, each having an overall simple topology
with two transmembrane domains, short cytoplasmic termini and a large ECD. Although it
was clear that the ECD has a defined and probably intricate structure, what this structure would
exactly look like was completely elusive.
The structure of an ASIC: post-crystal era
A deletion mutant of chicken ASIC1 has been
crystallized and the crystal structure has been
resolved at a resolution of 1.9 Å [20]. Since rat
and human ASIC1a are 90 % identical to
chicken ASIC1, it is very likely that many structural details are conserved in mammalian
ASIC1. Therefore and to have a common reference sequence, in this review all amino acids
are numbered based on the sequence of rat
ASIC1a. Initially, the chicken ASIC1 structure
was obtained from a deletion mutant where
most of the N- and C-termini had been deleted
[20]. Subsequently, a functional channel, in
which only the C-terminus was deleted but not
the N-terminus with its essential ”gating domain“, had been crystallized at a lower resolution (3 Å) [73]. The main difference between the
first crystal of a non-functional channel and the
second crystal of a functional channel was the
symmetric order of the two transmembrane domains in the functional channel [73]. Thus, the
high-resolution structure revealed the precise
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structure of the ECD, whereas the low-resolution
structure added the structure of the transmembrane domains and the ion pore. Both proteins
were crystallized at low pH (pH 5-6 and 6.5,
respectively), where chicken ASIC1 is desensitized. Therefore, most likely both structures represent the desensitized conformation of the
channel.
It came as a big surprise that chicken ASIC crystallized in units of two trimers [20]. Since crystals of the functional chicken ASIC also contained trimers as the basic unit [73], it is highly
likely that functional ASICs, and probably all
functional DEG/ENaC channels, are made of
three subunits. In the meanwhile, a trimeric
structure has been confirmed for ASIC1a by
atomic force microscopy imaging [74].
The ECD of each subunit resembles a clenched
hand, which is linked to the TMDs via an apparently flexible wrist [20]. The hand domain can
be divided in five subdomains: palm, finger,
thumb, and knuckle domains and a β-ball domain (Figure 3A). The contacts between the
subunits are in particular between different
palm domains and the palm domain of one subunit and the thumb domain of another. Prominent subunit interactions are 1) hydrogen bonds
between Asp78 (all numbers referring to rat
ASIC1a) of one subunit and His73 and Gln420 of
an adjacent subunit, 2) interactions between
the loops of β-strands in the palm domain and
the C terminus of helix α5 of the thumb domain
of an adjacent subunit, and 3) interactions between helix α6 of the knuckle that is enveloped
by a concave surface on the neighboring finger.
Most of the disulphide bonds localize to the
thumb (Figure 3B), giving it a rigid structure.
Since the thumb domain has contact with the
wrist junction via a conserved Trp (Trp287) residue (Figure 3A), its rigid structure may serve to
faithfully transduce conformational changes to
the transmembrane ion pore [20].
A peculiar feature of the structure was the clustering of several acidic amino acids within a
small space, the so-called acidic pocket. This
pocket is far (45 Å) from the TMDs and is
formed by intra-subunit contacts between the
thumb, the β-ball and the finger domains, together with residues from the palm domain of
an adjacent subunit [20] (Figure 3A). The acidic
pocket contains three pairs of acidic residues
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Figure 3: A) Model of the transmembrane topology of ASIC1a from the post-crystal era (based on reference [19]).
Three features of the structure and their crucial amino acids are magnified in the insets: the acidic pocket, the balland-socket joint and the Ca2+ binding site in the ion pore. Binding of a Ca2+ ion in the acidic pocket is hypothetical.
Note that all amino acids are numbered based on the sequence of rat ASIC1a. B) Linear model of ASIC1a highlighting
the relation of the primary sequence to the five subdomains of the ECD. It becomes apparent that the α-helices of the
finger, thumb and knuckle subdomains are contained within contiguous stretches of the polypeptide chain, whereas
the palm and β-ball domains are formed by β-sheets that are scattered over the polypeptide chain. Those β-sheets
connect the finger, thumb and knuckle subdomains. Note also that most of the cysteines (black dots) cluster within
the thumb subdomain (green), giving it a rigid structure. The structure of the cytoplasmic termini is unresolved.

(glutamate or aspartate), which form carboxylcarboxylate interactions. The distance of the
carboxyl groups is so small (2.8 – 3.0 Å; [20])
that at least one of the carboxyl groups of each
pair must be protonated. This means that the
pKa value of one residue of each pair is several
units larger than that of isolated Asp or Glu residues.

are tilted by ~50o with respect to the membrane
and cross each other in the middle of the membrane bilayer [73]. Thus, in line with previous
functional studies [52-65], TMD2 helices probably line the ion pore. The TMD1 helices make
most contacts with the lipid bilayer but also with
TMD2 helices of the same subunit and the
TMD1 and TMD2 helices of adjacent subunits.

TMD1 and TMD2 of the three subunits form αhelices [73]. Whereas in the crystal of the nonfunctional protein TMDs were asymmetric, in
the crystal of the functional channel they are
symmetric, providing the structure of the ion
pore in the desensitized conformation. The
TMD2 helices are closest to the three-fold axis,

In the desensitized conformation, two cationbinding sites have been revealed by soaking the
crystal in solutions containing Cs+. In both sites,
Cs+ is coordinated by six ligands arranged in a
trigonal antiprism geometry. At site 1, Cs+ is
coordinated by three side chain carboxyl groups
of Asp432. At site 2, ligands consist of either

79

Int J Physiol Pathophysiol Pharmacol 2010;2(2):73-94

Acid-sensing ion channels

Figure 4: Model of ASIC1a showing the
three vestibules in the ECD and the lateral access to the extracellular vestibule
via a lateral fenestration (based on reference [72]). Acidic amino acids that line
the central and extracellular vestibules
are indicated; they are numbered based
on the sequence of rat ASIC1a. The negative charge of their side chains could
attract cations to the vestibules.

main-chain carbonyl oxygen atoms from Gly431
or side chain oxygen atoms from Asp432. Moreover, it was suggested that main-chain carbonyl
oxygen atoms, derived mainly from glycine residues, also coordinate permeant ions in the
open channel. Thus, G431 and G435 could build a
third ion-binding site in the open conformation
of the channel [73]. Other candidates for glycines involved in ion coordination are G438 and
G442 [73]. G442 is the first of the three residues
proposed by earlier studies to form the selectivity filter [54, 56, 60] (Figure 2B).
In the desensitized conformation, three vestibules can be discerned in the ECD, along the
central axis of the channel [73] (Figure 4). The
upper vestibule is in direct contact with the extracellular solution, whereas the central and the
extracellular vestibule, which is situated at the
height of the outer surface of the membrane,
are separated from each other and the upper
vestibule by constrictions. If these constrictions
would be wider in the open channel, they would
form a central tunnel, constituting a pathway for
ions to the pore. Cations would be concentrated
within the vestibules along the central tunnel by
several acidic residues, clustered in the central
and extracellular vestibules (Figure 4). In addition to this putative central pathway for ions, in
the desensitized conformation, there is direct
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access to the extracellular vestibule through
three lateral fenestrations at the wrist of the
ECD.
Even with the lateral access pathway to the extracellular vestibule, ions cannot permeate
through the pore because, in the desensitized
conformation, TMD2 helices cross each other in
the middle of the membrane bilayer. Thus, the
helices apparently change their conformation
during desensitization, constricting the ion pore.
This constriction therefore constitutes the desensitization gate – a physical block of the ion
pore (Figure 4). Close packing of the three
TMD2 helices at the constriction is made possible by Gly435.
The speed of the desensitization is determined
by three amino acids in the proximal ectodomain (S83-T85) [10]. Moreover, a residue in the
immediate vicinity (E79) is modified by cysteinemodifying reagents in the closed but not the
desensitized conformation [30], suggesting that
this residue undergoes a conformation change
during desensitization gating of the channel.
Together these results suggest that the loop
encompassing residues E79-T85, which localizes
between the palm and the β-ball domains, undergoes a conformation change during desensitization gating that determines the speed of
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desensitization.
In summary, the crystal structure of chicken
ASIC1 provides an invaluable picture of the intricate three-dimensional structure of the ECD and
the ion pore. It suggests models for ion permeation and selectivity in these channels and, as we
will see, it also suggests models for H+-gating of
ASICs. One has to keep in mind, however, that
the chicken ASIC1 structure is a snapshot of the
desensitized state of the channel. A clear picture of the conformational changes accompanying ASIC gating needs additional crystal structures of, ideally, the closed and the open states.
In the absence of these structures, the first crystal structure can nevertheless guide future
structure-function studies and greatly refine
models of ASIC gating.
How to gate an ASIC by H+
In principle, titration of a single amino acid of an
ASIC, for example in the ECD, could induce a
conformational change, opening the ion pore.
Current models of ASIC gating, however, invoke
a more complicated process to explain ASIC
gating.
An initial observation providing a clue to ASIC
gating came from the observation that extracellular Ca2+ ions modulate the apparent H+ affinity
of ASIC1: high [Ca2+]e decreases apparent H+
affinity (higher H+ concentrations are needed to
open the pore) and low [Ca2+]e increases apparent H+ affinity (lower H+ concentrations are
needed to open the pore) [25]. To explain these
findings, it was proposed that Ca2+ stabilizes the
closed state of the channel and that H+ displaces Ca2+ from its binding site, effectively
competing with Ca2+ for this binding site [25].
This model was then extended for ASIC3 by proposing that a Ca2+ ion in fact blocks the open
ASIC pore. According to this model, H+ would
gate an ASIC open by unblocking the ion pore
with no accompanying conformational change
[75].
Substitution of D432 and E425 at the N-terminal
end of TMD2 by neutral amino acids disrupted
pore block of ASIC1a by Ca2+ [35]. The crystal
structure of cASIC1 confirmed that D432 and
E425 are accessible from the aqueous phase
within the extracellular vestibule; moreover,
D432 forms a putative binding site for cations at
the bottom of the extracellular vestibule [73]

81

(Figure 3A), suggesting that substitution of D432
and E425 disrupted the Ca2+ binding site in the
outer pore of ASIC1a. In addition, voltage clamp
fluorometric measurements showed that E425
undergoes a significant reorganization following
extracellular acidification [76], in agreement
with the idea that such a movement is associated with relief of Ca2+ blockade. This Ca2+ binding site mutant, therefore, allowed testing of the
pore block model. According to this model, disruption of the Ca2+ binding site should have
three effects: first and most importantly, the ion
pore should be constitutively open, second, the
channel should be no longer gated by H+ and
third, Ca2+ should no longer modulate the apparent affinity for H+. All three predicted effects
were not observed: mutant channels were not
constitutively open, they were still gated by H+
and their apparent H+ affinity was still modulated by Ca2+ [35]. These results effectively rule
out the possibility that pore block by Ca2+ can
fully explain gating of ASIC1. Examination of
single channel recordings of ASIC1 from toadfish also argued against the Ca2+ pore block
model and favored an allosteric model to explain ASIC gating [77]. Moreover, modulation by
a spider toxin (psalmotoxin 1, see below) of chimeras between ASIC1a and 1b suggested the
existence of partially-liganded open states of
ASIC1 [78], a finding, which is in agreement
with a Monod-Wyman-Changeux model for cooperativity in allosteric proteins.
Channels with the Ca2+ binding site mutations
(D432 and E425) had, however, reduced affinity
for H+, a smaller Hill co-efficient and modulation
by Ca2+ was less pronounced [35], suggesting
that pore block by Ca2+ contributes to ASIC gating. This interpretation suggests the existence
of two Ca2+ binding sites involved in ASIC gating:
one at the outer entrance to the ion pore, crucial determinants are D432 and E425, and another one at a different location within the ECD.
The acidic pocket is suspicious of such a second putative Ca2+ binding site within the ECD
[20]. Pairs of acidic amino acids within the
acidic pocket are D237-D349, E238-D345, and E219D407 (Figure 3A); E79-E416 defines a fourth pair
outside the acidic pocket [20].
Since the crystal probably represents the structure of the desensitized conformation, it has
been hypothesized that, in the closed state, the
acidic pocket held a Ca2+ ion that was displaced
upon acidification when one of the acidic resi-
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dues of each pair became protonated [20]. This
is an attractive and plausible hypothesis that is
supported by the experimental finding that E79,
which is in an acidic pair, is inaccessible for
cysteine-modifying reagents in the desensitized
but not the closed state [30]. Moreover, molecular simulations of cation binding to the structure
of chicken ASIC1 revealed that Ca2+ binds to the
acidic pocket, but only when all three pairs of
acidic residues are charged, and that H+ binding
inhibits Ca2+ binding at this site [79]. Evidence
for cation binding was especially strong for the
two pairs D237-D349 and E238-D345 [79]. Individual
mutations of amino acids of the acidic pocket
have rather modest effects on ASIC gating [20,
80], however, and even combined substitution
of all four amino acids from the two critical pairs
(D237-D349, E238-D345) did not disrupt proton gating of an ASIC [81]. These results suggest that
there are further determinants of ASIC gating.
Indeed molecular simulations suggested the
surface residue pairs D298-D331 and E338-E342 as
additional potential candidates for H+ sensing
sites of ASIC1a [79]; these sites are not conserved in other H+-sensitive ASICs (e.g. ASIC3),
however, suggesting that if they have a role in
ASIC gating it must be a rather modulatory role.
In addition to titration of acidic residues within
Ca2+-binding sites, H+ may also titrate amino
acids that contribute to open gating of an ASIC
by an allosteric mechanism. Indeed some years
ago, a histidine that is highly conserved in ASICs
has already been shown to be important for H+
gating of ASIC2a [82]. ASIC1a has two adjacent
histidines at the corresponding position (H72/
H73) and in a large screen for amino acids involved in gating of ASIC1a, these same two histidines were found to be indispensable for
ASIC1a gating [80], confirming the importance
of these His residues. In this screen, D78 and
E79 were also found to be important for ASIC1a
gating, but only when combined with the Ca2+
binding site mutations in the pore (D432 and
E425) [80]. Interestingly, in the desensitized conformation, D78 forms a hydrogen bond with H73
[20] and E79 forms a carboxyl-carboxylate pair
with E416, supporting an important function of
these two residues. Molecular simulations suggested that the E79-E416 pair, in contrast to the
pairs from the acidic pocket (D237-D349, E238D345, and E219-D407), preferentially binds Na+
over Ca2+ ions [79], suggesting a role in ion permeation for E79. Although their exact role is still
unknown, collectively current evidence suggests
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a crucial role for H72/H73, D78, and E79 in ASIC
gating. Indeed the presence of these amino
acids has been successfully used to predict H+sensitivity of ASIC1b from shark [83].
Several studies used chimeric approaches to
identify the regions that are responsible for differential H+ sensitivity of different ASICs. Such
regions do not necessarily contain crucial H+
binding sites, however. In one such approach
with chimeras between rat ASIC1a and 1b, two
amino acids (K105N106) that localize to the finger
domain were identified where substitutions convert the relatively high apparent H+ affinity of
ASIC1a into the lower affinity of ASIC1b [25].
Molecular simulation also suggested that the
finger domain moves during gating [79]. In another study with chimeras between rat ASIC1a
and 2a, two larger regions (from amino acid 87 197 and from 323 – 431) were identified that
specify the different H+ sensitivities of these two
ASICs [84]. ASIC2a has a rather low H+ sensitivity, however, explaining the larger regions necessary to swap sensitivities.
Based on current evidence it has been proposed [80] that upon acidification, H73 (and
perhaps H72) gets protonated, which induces a
conformational change, facilitating the displacement of Ca2+ ions from its binding sites in the
pore and the acidic pocket. Concomitantly,
charged residues of the Ca2+ binding sites get
protonated and form the carboxyl-carboxylate
pairs. The conformational change is probably
accompanied by a movement of the palm domain relative to the thumb domain. Movement
of the thumb domain is then likely transferred to
the TMDs to open the ion pore. Voltage clamp
fluorometry indeed suggests that the pre-TMD2
region changes its conformation upon acidification [76]. The crucial role of the thumb domain
in transferring the conformational changes of
the ECD to the TMDs is suggested by the close
contact of Tyr71 and Trp287 (at the base of the
thumb in immediate contact to the wrist junction) in the cASIC crystal [20]. It has been proposed that these two residues form a ball-andsocket joint to transduce conformational
changes of the ECD to the TMDs [20] (Figure
3A). Moreover, the importance of the interaction
between Y71 and W287 for ASIC gating has recently been experimentally confirmed [81]. In
addition, amino acid changes in the region
around W287 determine the differential H+ sensitivity of SSD of mouse and human ASIC1a [27].
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Table 1: Inhibitory constants (IC50) of different inhibitors at homomeric ASIC1a and ASIC currents in cultured neurons. ND, not determined
Reference
IC50 at ASIC1a
IC50 at ASIC in neurons
Inhibitor
[µM]
[µM]
Zn2+
0.007
~0.015
[87]
ND
~50
[90]
Cu2+
~5
~10
[91]
Pb2+
Cd2+
no inhibition
ND
[92]
ND
[92]
Ni2+
~600
PcTx1
~0.001 (at pH 7.4)
ND
[95]
amiloride
nafamostat
ibuprofen
flurbiprofen
A-317567
DAPI
pentamidine
hydroxystilbamidine
diminazene

10
~15
~350
~350
ND
ND
ND
ND
2-3

Desensitization would then be accompanied by
a movement of the loop encompassing residues
E79-T85, which is probably accompanied by rotation of the adjacent residues D78 towards H73
and E79 towards E416, and finally by constriction
of the ion pore in the middle of TMD2. This is a
tentative and hypothetical model. What is quite
clear is that ASIC gating critically involves several residues scattered over the ECD, with residues at the wrist junction having a central role.
Pharmacology of ASIC1
The pharmacology of ASIC inhibitors and their
therapeutic potentials have been reviewed previously [85-87]. Here we summarize recent findings from the view of structure-function relationships.
Chemically, there are three classes of ASIC inhibitors: metal ions, polypeptide toxins, and
small-molecule inhibitors (table 1). Besides Ca2+
and Mg2+, a number of divalent and trivalent
metal ions inhibit ASICs. PcTx1 is a cysteine-rich
high-affinity polypeptide toxin purified from a
tarantula venom. Amiloride, A-317567, nafamostat and diarylamidines are examples for synthetic, small molecule ASIC inhibitors.
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10 - 50
ND
ND
ND
2 - 30
3
40
1.5
0.3

[3]
[121]
[122]
[122]
[123]
[124]
[124]
[124]
[124]

Metal ions
Currently zinc, copper, lead, nickel, and cadmium have been documented to affect ASIC1a.
Zinc (Zn2+), an endogenous trace element, inhibits homomeric ASIC1a and heteromeric
ASIC1a/2a with nanomolar affinity, without affecting currents mediated by homomeric
ASIC1b, ASIC2a, or ASIC3 [88]. In agreement
with high-affinity Zn2+-inhibition of the major
ASICs in the CNS (ASIC1a and ASIC1a/2a), chelation of trace amounts of Zn2+ by TPEN, a Zn2+/
Fe2+ chelator with low affinity for Ca2+, potentiates approximately two-fold ASIC currents in
cultured mouse cortical neurons [88]. Likewise,
sulfhydryl-containing reducing agents like dithiothreitol potentiate ASIC currents in hippocampal
neurons, mainly by chelating metal ions that
tonically inhibit ASIC1a and ASIC1a/2a [89].
Homomeric ASIC1a is more strongly inhibited by
Zn2+ than heteromeric ASIC1a/2a [88]. At much
higher (micromolar) concentrations, Zn2+ has an
opposite effect and potentiates currents
through homomeric ASIC2a and heteromeric
ASIC1a/2a (EC50: ~100 µM), but not through
homomeric ASIC1a [82]. In addition, such high
concentrations of Zn2+ slow the decay time constant of ASIC currents in hippocampal neurons
[90]. High-affinity Zn2+-block depends on K133 in
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the ECD of ASIC1a [88] whereas Zn2+potentiation depends on H162 and H339 in the
ECD of ASIC2a [82].
Micromolar concentrations of copper (Cu2+) inhibit ASIC currents in cultured hypothalamic
neurons (IC50: ~50 µM) [91] and the neurotoxic
metal ion lead (Pb2+) strongly and reversibly
blocks ASIC1a-containing homo- and heteromeric channels (IC50: ~5 µM) [92]. Nickel (Ni2+)
and cadmium (Cd2+) affect some ASIC currents
at high concentrations (1 mM) [93]. At this concentration, Ni2+ inhibits homomeric ASIC1a and
heteromeric ASIC1a/2a [93]. In contrast, Cd2+,
up to 1 mM, does not affect homomeric ASIC1a
currents [93]. Since Cd2+ blocks voltage-gated
calcium channels [94, 95], it can be used as a
pharmacological tool to distinguish between
ASIC1a and voltage-gated calcium channels as
a source of acid-evoked calcium influx in neurons.

ischemic stroke and since it contributes to axonal degeneration in autoimmune inflammation, this finding implies a new approach to intervene with ASIC1a activity: to pharmacologically facilitate its steady-state desensitization by
slightly increasing its H+ affinity. Such an approach is hampered, however, by the comparatively low H+ affinity of SSD of human ASIC1a
[27].

Polypeptide toxins

PcTx1 does not inhibit ASIC1b but rather increases the proton affinity of ASIC1b and shifts
its pH-activation curve to higher pH values.
PcTx1 directly opens ASIC1b under slightly
acidic conditions. In addition, PcTx1 significantly
slows the desensitization process of ASIC1b,
but not of ASIC1a. These data strongly support a
model of state dependent binding, i.e. PcTx1
has different affinities for the closed, open, and
desensitized states of the channels. For ASIC1a,
it stabilizes the desensitized state promoting
SSD, whereas for ASIC1b, it stabilizes the open
state promoting channel opening [78].

Psalmotoxin 1 (PcTx1) is a polypeptide toxin
isolated from the venom of the South American
tarantula Psalmopoeus cambridgei and specifically inhibits homomeric ASIC1a with an IC50 of
~ 1 nM. PcTx1 does not inhibit other ASIC subtypes or voltage-gated ion channels [96] and
has already proven to be a useful pharmacological tool for probing the functions of ASIC1a in
vivo [97-100]. PcTx1 consists of 40 amino acids, containing 6 cysteines that form three disulfide bridges. The solution structure of PcTx1 has
been determined [101] and, interestingly, PcTx1
is structurally similar to a class of gating modifier toxins of voltage-gated ion channels, such
as Hanatoxin 1 [101]. Like Hanatoxin 1, PcTx1
has a canonical inhibitor cysteine knot (ICK)
scaffold, which possesses an embedded ring
formed by two disulfide bonds and their connecting backbone segments which is threaded
by a third disulfide bond [101, 102]. Spider toxins most often modify the voltage dependence
of voltage-gated ion channels [103-106] or slow
their inactivation kinetics [107, 108]. PcTx1
inhibits ASIC1a in a similar manner: it increases
the apparent ligand affinity of ASIC1a [109].
Since ASIC1a is activated by H+ at concentrations that are only slightly higher than the resting H+ concentrations, this increase in H+ affinity
is sufficient to transfer ASIC1a channels into the
desensitized state. Since ASIC1 has been implicated in the neurodegeneration accompanying

First hints on the PcTx1 binding site came from
mutagenesis studies, in which chimeras between ASIC1a and ASIC2a and/or 1b were assessed for binding of radiolabelled PcTx1 [110]
or for PcTx1-inhibition of proton-gated currents
[78, 110]. One of these studies identified amino
acids 167-185 in the ECD of ASIC1a that determines a high PcTx1 affinity of the desensitized
state of ASIC1a [78]. Another study identified
the same region plus a second region (amino
acids 271-369) in the ECD [110]. The involvement of both domains in PcTx1 binding was
recently confirmed by computational docking
simulations [111, 112], which revealed that
PcTx1 binds to a pocket in the ECD of ASIC1a
which is formed by four structural motifs: the
two stretches identified with the chimeric channels (amino acids 167-185 and the distal part
of stretch 271-369), an additional region comprising amino acids 113-129, and E219 [111,
112]. Moreover, molecular docking revealed
that PcTx1 binds at the interface of two subunits and that the domains constituting the high
-affinity binding site are located on two adjacent
subunits [111, 112]. The crucial role of the distal part of the stretch from amino acids 271369 was recently confirmed by the finding that
the F350L substitution (F352 in human ASIC1a)
completely eliminated the modulation of ASIC1a
by PcTx1 [84]. Since PcTx1 competes with
dynorphin for binding to ASIC1a [31], the bind-
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ing site for dynorphin may overlap with the
PcTx1 binding site.
Recently, it was demonstrated that PcTx1
strongly activates chicken ASIC1a even at neutral pH [34]. Therefore, PcTx1 functions as an
allosteric agonist for cASIC1, providing a novel
tool for elucidating the gating mechanism of
cASIC1. This finding also provides an explanation why a tarantula venom contains a toxin that
targets ASIC1. From an evolutionary point of
view, PcTx1 may have been generated by the
tarantula as an activator rather than as an inhibitor of ASICs so as to ward off its potential
predators (such as birds) because activating
ASICs would cause pain or inflammation. Similar
examples from nature are vanillotoxins that are
contained within the venom of the same tarantula species (Psalmopoeus cambridgei). Vanillotoxins share high homology and a conserved
cysteine bridge pattern with PcTx1 and directly
open TRPV1 channels [113] to cause pain as a
defending strategy. The result that PcTx1 directly gates chicken or rat ASIC1, thus, supports
the idea that ASICs are involved in pain perception. Therefore, blocking ASIC1 may have beneficial effects in relieving pain. Indeed it has been
shown that PcTx1 has potent analgesic properties against thermal, mechanical, chemical, inflammatory and neuropathic pain in rodents
[100].
Small-molecule inhibitors
The diuretic amiloride is an open channel
blocker plugging the ion pore [35] and is viewed
as a prototype blocker of ASIC channels. Amiloride blocks ASIC1a currents with an IC50 of 10
µM [16, 114]. It is not very selective and inhibits, among others, ENaC, T-type calcium channels, and the sodium-proton exchanger [86]. In
peripheral sensory neurons, amiloride has been
used to suppress acid-induced pain [115, 116],
whereas in CNS neurons, it reduces acidmediated ischemic neuronal injury and axonal
degeneration [97, 98]. Both effects are potentially mediated by the inhibition of ASICs.
Nafamostat, a synthetic, competitive serine protease inhibitor that is clinically used for the
treatment of disseminated intravascular coagulation and acute pancreatitis [117-121], has
recently been identified as an inhibitor of ASICs
[122]. In contrast to amiloride, nafamostat inhibits ENaC (IC50: ~1 mM) less potently than
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ASICs (IC50: ~2 – 70 µM, depending on the subtype). Non-steroidal anti-inflammatory drugs,
such as diclofenac and ibuprofen, directly inhibit ASICs in nociceptors but with relatively low
potency [123]. Ibuprofen and its analogue flurbiprofen inhibit ASIC1a with an IC50 of 350 µM,
whereas diclofenac inhibits ASIC3 (IC50: 100
µM) but not ASIC1a [123]. A-317567, a novel
non-diuretic blocker, inhibits three distinct types
of native ASIC currents of acutely dissociated
adult rat dorsal root ganglion (DRG) neurons
[124].
Through a small scale screen, anti-protozoal
diarylamidines, including diminazene, hydroxystilbamidine (HSB), and pentamidine were recently identified as potent inhibitors of ASICs in
primary cultured hippocampal neurons as well
as of ASICs over-expressed in CHO cells or in
Xenopus oocytes [125]. Diarylamidines have
been widely used for the treatment of protozoal
diseases such as trypanosomiasis and leishmaniasis since the 1930s [126-128]. Diarylamidines such as diminazene are lead compounds
that point to a new route to identify new potent
and selective inhibitors of ASICs. Diminazene is
the most potent small molecule inhibitor of
ASICs known so far (IC50: 0.3 µM, measured in
cultured hippocampal neurons). It has distinct
potency on different ASIC subtypes. It blocks
homomeric ASIC currents expressed in CHO
cells with a rank order of potency 1b > 3 > 2a >
1a. Intriguingly, anti-parasitic diarylamidines
comprise more than 30 members and the family number is rapidly increasing due to medical
needs in the treatment of pneumocystosis, African trypanosomiasis and leishmaniasis. Thus, it
is feasible to select these compounds from the
chemical family of diarylamidines to test their
inhibitory effects on ASICs and to possibly identify new selective and potent ASIC blockers with
therapeutic potential.
Comparison of nafamostat with diarylamidines
reveals that both are dications which are governed by amidine/guandine groups at their termini, with variable bulk (like benzene rings) on
the outer edge of the molecule linked by molecular bridges of varying length and composition. Their difference lies in that nafamostat has
a guanidine group at one terminus and an
amidine group at the other, while diarylamidines
have amidine groups at both ends. It is not surprising that dicationic diarylamidines or nafamostat block ASIC potently as the ectodomain of
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ASICs has a large number of negatively charged
amino acids [80].
A “patchdock” computation technique was used
to dock nafamostat, diminazene, HSB and pentamidine, respectively, to the ASIC1 crystal
structure and to analyze possible binding domains of these compounds [125]. This analysis
suggests that these dicationic compounds likely
bind to a groove formed by part of the β-ball and
palm domains of ASICs [125]. Specifically, residues in a stretch from F174 to L207 shape this
groove [125]. Thus, this domain partly overlaps
with the PxTc1 binding site. So far, there is no
selective small-molecule inhibitor for ASICs,
mainly because the potency of the known inhibitors is relatively low. Further structure-function
studies and larger screens based on the cASIC1
crystal structure and the common template of
diarylamidines may lead to the identification of
more potent and subtype-specific blockers of
ASICs.
Regarding the pharmacological classification of
known ASIC inhibitors, they fall into three
classes: gating modifiers (PcTx1), noncompetitive antagonists (probably diminazene
and nafamostat) and un-competitive antagonists (pore blocker amiloride). Ca2+ and Mg2+
might be competitive antagonists.
Physiological functions and pathophysiology of
ASIC1
ASICs are predominantly, though not exclusively,
expressed throughout the PNS and CNS. In the
CNS, ASIC1a is abundantly present in the hippocampus, cortex, striatum, olfactory bulb and
elsewhere, with a particularly high expression in
the amygdala [129]. Low pH-induced ASIC currents are detected in virtually every cultured
neuron from spinal dorsal horn [130], cortex
[97], and hippocampus [22, 23]. In contrast,
ASIC currents are not detectable in glial cells
[131, 132] and we were unable to detect ASIC
currents by puff-application of pH 5.8 to microglia in acute cortical slices (X.C., unpublished).
However, the presence of ASIC-like currents has
been documented in cells of the oligodendrocyte lineage [133, 134] and in glioblastoma
cells [132].
What is the function of ASICs in central neurons? Synaptic vesicles are acidic [135] and it is
conceivable that the release of the content of
the synaptic vesicles sufficiently acidifies the
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synaptic cleft [136] to activate ASICs. In agreement with such a scenario, in transfected cultured hippocampal neurons, ASIC1a has a synaptic pattern of distribution and co-localizes
with the postsynaptic marker PSD95 but not
with the axonal marker dephospho tau-1 [137].
ASIC1a transfected into hippocampal slices also
has somatodendritic localization and is present
in most spines [138]. Moreover, ASIC2, which
can tether to PSD95 (in contrast to ASIC1a),
facilitates ASIC1a localization at dendritic
spines by direct association with ASIC1a [139].
In addition, there is evidence that ASIC1a modulates the density of dendritic spines [138]. The
presumably postsynaptic location of ASIC1a
together with its Na+-selectivity, thus, suggests
that ASIC1a contributes to the excitatory postsynaptic current in many neurons.
In agreement with this hypothesis, knock out of
the asic1 gene in mice reduces excitatory postsynaptic potentials during high-frequency electric stimulation and impairs long-term potentiation (LTP) at Schaffer collateral-CA1 synapses in
the hippocampus [137]. In contrast, baseline
synaptic transmission is normal in those mice
[137]. It is plausible that ASIC1a facilitates neuronal depolarization especially during high frequency stimulation and thus may promote the
opening of NMDA receptors, activation of which
is a central feature of CA1 LTP. However, the
exact role of ASIC1a in LTP is not fully understood. Behaviorally, ASIC1a null mice display
defective spatial learning and defective cerebellum-dependent eyeblink conditioning [137].
Consistent with the robust expression of ASIC1a
in lateral and basolateral nuclei of the amygdala
and in the hippocampus [129, 137, 140], mice
lacking ASIC1 also exhibit deficits in multiple
fear-related behaviors including unconditioned
fear, and the acquisition and retention of conditioned fear [129, 140]. Conversely, overexpressing ASIC1a throughout the brain in a
transgenic mouse enhances context fear conditioning [141]. Restoring ASIC1a function specifically in the amygdala of ASIC1 knockout mice
with a viral vector rescues fear memory but not
unconditioned fear responses [142]. Finally,
ASIC1a was recently shown to be a chemosensor in the amygdala detecting carbon dioxide
and acidosis that elicits fear behavior [26]. In
line with an important role in the fear circuit,
genetically disrupting or pharmacologically inhibiting ASIC1 has antidepressant-like effects
[143], establishing ASIC1a as a new possible
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target to combat depression.
Somewhat contradictory to its excitatory role,
some studies point to an inhibitory role of
ASIC1a. One recent study suggested that
ASIC1a could exert some protective effects in
the brain under epileptic conditions [99]. This
study combined genetic, pharmacological, and
electrophysiological approaches with animal
behavioral analysis to examine how ASIC1a
works under epileptic conditions. It was found
that ASIC1a facilitates termination of seizures
rather than causing neuronal over-excitation
[99]. ASIC1a reduces seizure severity, shortens
seizure duration, and promotes seizure termination [99]. Transgenic over-expression of ASIC1a
had beneficial effects without affecting seizure
threshold, while ASIC1a ablation had opposite
effects and increased seizure severity and reduced postictal depression of epilepsy and thus
increased seizure-caused mortality [99]. Thus,
there is solid evidence that ASIC1a mediates
the antiepileptic effects of extracellular acidosis
during epilepsy. But how can an excitatory channel dampen neuronal over-excitation? To explain this paradox, a mechanistic model was
proposed that activation of ASIC1a in inhibitory
interneurons of the hippocampus, which have
larger ASIC currents than excitatory pyramidal
neurons [99], could increase the inhibitory tone
and thereby attenuate epileptic activities [99].
Thus, according to this model, ASIC1a is an excitatory ionotropic receptor, but its predominant
expression in inhibitory neurons would increase
the inhibitory tone in a network during ASIC1a
activation.
A similar model may explain increased (rather
than reduced) pain sensitivity in mice with a
loss of ASIC function. A dominant-negative
ASIC3 subunit assembles with other ASIC subunits and transgenic expression of this subunit
leads to a complete loss of ASIC-like currents to
pH 5.0 stimulation in DRG neurons [144]. Unexpectedly, in these transgenic mice sensitivity to
mechanic and inflammatory pain is increased
rather than reduced [144]. Similarly, ASIC3 null
mice show enhanced behavioral responses to
high-intensity nociceptive stimuli [145]. This
increased pain sensitivity may again be explained by the precise location of ASICs within
the pain pathway.
But there are also observations suggesting that
ASICs might down-regulate excitability of individual neurons. For example, presynaptic release
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probability is enhanced in hippocampal neurons
from ASIC1 null mice [146]. Moreover, in the
retina ASIC2a negatively modulates rod phototransduction and protects the retina from lightinduced degeneration [147]. ASIC1a, however,
is a positive modulator of cone phototransduction and adaptation [148]. Although the exact
role of different ASICs in signal transduction in
the retina is unknown, these studies support
the possibility that ASICs, under certain circumstances, might function as negative regulators
instead of depolarizing elements in the course
of synaptic transmission.
In addition to its roles in fear conditioning and
seizure termination, ASIC1a apparently gets
activated during the course of a number of neuropathological syndromes such as brain ischemia, autoimmune inflammation, or inflammation-associated pain. A prolonged acidosis is
common to all these syndromes; how completely desensitizing ASIC1a gets activated during prolonged acidosis is unknown. Since extracellular acidosis increases neuronal cell calcium by activating ASIC1a [33, 138], ASIC1a
activation might enhance brain injury, for example during the ischemia associated with stroke.
Indeed ASIC1a was found to have a significant
detrimental effect on neuronal survival under
ischemic conditions [97]. In the focal ischemia
model, intracerebroventricular injection of
ASIC1a blockers (amiloride, PcTX1) or knockout
of the ASIC1a gene protects the brain from
ischemic injury [97]. Furthermore, post-ischemic
administration of PcTx1 was found to be neuroprotective against brain ischemic injury in the
transient middle cerebral artery occlusion
model [149]. In addition and as mentioned before, there is evidence that ASIC1a functionally
couples to NMDA receptors. Consequently, activation of ASIC1a may exacerbate neuronal
death during ischemia also by coupling to
NMDA receptors [150]. These findings identify
ASIC1a as an emerging non-classical excitotoxic
therapeutic target for combating stroke [151].
In a mouse model for experimental autoimmune
encephalomyelitis (EAE), ASIC1a mRNA is upregulated and genetic disruption of ASIC1 or
pharmacological inhibition by amiloride ameliorates disease severity and axonal loss in EAE
mice [98]. Axonal degeneration may be initiated
by activation of ASIC1a localized to dendrites or
cell bodies or alternatively, ASIC1a may be abnormally distributed to demyelinated axons in
inflamed EAE lesions [98].
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In the PNS, ASIC1a is expressed together with
other ASICs (ASIC1b, 2a, 2b, and 3) in sensory
neurons of the dorsal root ganglion (DRG) and
trigeminal ganglion (TG) [123, 152, 153]. Moreover, homomeric ASIC1a and heteromeric
ASIC1a/2a are the predominant ASICs in neurons of the spinal dorsal horn [130, 154]. During inflammation, ASIC1a expression increases
in the DRGs [123, 155] and the spinal horn
[114, 154]. Increased ASIC1a expression most
likely contributes to enhanced pain during inflammation [100, 156]. In agreement with this
hypothesis, spinal infusion of PcTx1 or ASIC1a
antisense oligonucleotides attenuated thermal
and mechanical hypersensitivity [154], suggesting that ASIC1a contributes to central sensitization.
In summary, in the last decade we learned a lot
about the roles of ASIC1a in the central nervous
system and in neuropathological conditions.
Many aspects of its action remain mysterious,
however, suggesting that the study of ASIC1a
will lead to further exciting discoveries in the
future.
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